Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 12:27 pm Sale | 13G | Xometry Inc. XMTR | EVENTIDE ASSET MANAGEMENT LLC | 4,418,664 9.480% | -1,309,106 (-22.86%) | View |
| 2024-11-14 12:25 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 3,445,363 7.220% | 751,782 (+27.91%) | View |
| 2024-11-14 12:24 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -4,529,997 (Position Closed) | View |
| 2024-11-14 12:23 pm Sale | 13G | Lexeo Therapeutics Inc. LXEO | EVENTIDE ASSET MANAGEMENT LLC | 1,855,986 5.610% | -336,225 (-15.34%) | View |
| 2024-11-14 12:21 pm Sale | 13G | Korro Bio Inc. KRRO | EVENTIDE ASSET MANAGEMENT LLC | 391,166 4.210% | -155,159 (-28.40%) | View |
| 2024-11-14 12:19 pm Purchase | 13G | INOZYME PHARMA INC INZY | EVENTIDE ASSET MANAGEMENT LLC | 4,134,436 6.440% | 954,599 (+30.02%) | View |
| 2024-11-14 12:18 pm Sale | 13G | Celldex Therapeutics Inc. CLDX | EVENTIDE ASSET MANAGEMENT LLC | 3,332,005 5.030% | -298,008 (-8.21%) | View |
| 2024-11-14 12:17 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | EVENTIDE ASSET MANAGEMENT LLC | 9,400,000 5.110% | 9,400,000 (New Position) | View |
| 2024-11-06 2:47 pm Sale | 13G | Zentalis Pharmaceuticals Inc. ZNTL | EVENTIDE ASSET MANAGEMENT LLC | 7,090,108 9.970% | -4,469,867 (-38.67%) | View |
| 2024-08-09 09:43 am Sale | 13G | Lexeo Therapeutics Inc. LXEO | EVENTIDE ASSET MANAGEMENT LLC | 2,192,211 6.650% | -810,620 (-27.00%) | View |
| 2024-02-14 12:49 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,693,581 5.780% | 636,581 (+30.95%) | View |
| 2024-02-14 12:43 pm Sale | 13G | Annexon Inc. ANNX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -3,626,508 (Position Closed) | View |
| 2024-02-14 12:36 pm Sale | 13G | Xometry Inc. XMTR | EVENTIDE ASSET MANAGEMENT LLC | 5,727,770 12.620% | -2,569 (-0.04%) | View |
| 2024-02-14 12:29 pm Sale | 13G | VectivBio Holding AG VECT | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -3,405,644 (Position Closed) | View |
| 2024-02-14 12:21 pm Unchanged | 13G | Praxis Precision Medicines Inc. PRAX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-14 12:18 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | EVENTIDE ASSET MANAGEMENT LLC | 4,529,997 8.300% | 1,379,997 (+43.81%) | View |
| 2024-02-14 12:15 pm Unchanged | 13G | Freeline Therapeutics Holdings plc FRLN | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-14 12:04 pm Purchase | 13G | COLLEGIUM PHARMACEUTICAL INC COLL | EVENTIDE ASSET MANAGEMENT LLC | 2,630,478 8.070% | 885 (+0.03%) | View |
| 2024-02-14 12:02 pm Sale | 13G | 908 DEVICES INC MASS | EVENTIDE ASSET MANAGEMENT LLC | 1,430,995 4.420% | -799,670 (-35.85%) | View |
| 2024-02-14 11:59 am Purchase | 13G | Korro Bio Inc. KRRO | EVENTIDE ASSET MANAGEMENT LLC | 546,325 6.830% | 546,325 (New Position) | View |